Use of linear and multiple antigenic peptides in the immunodiagnosis of acute hepatitis A virus infection

Journal of Immunological Methods

Volumn 234, Issue 1-2, 2000, Pages 23-34

  Gomara M J ^a   Riedemann, S ^b   Vega, I ^b   Ibarra, H ^b   Ercilla, G ^c   Haro, I ^a  

^a DEPARTMENT OF ENVIRONMENTAL CHEMISTRY   (Spain)

^b UNIVERSIDAD AUSTRAL DE CHILE   (Chile)

^c HOSPITAL CLÍNIC   (Spain)

Author keywords

ELISA; Hepatitis A; Immunodiagnosis; Lipopeptides; Multiple antigenic peptides; Synthetic peptides

Indexed keywords

CAPSID PROTEIN; IMMUNOGLOBULIN M ANTIBODY; LIPOPEPTIDE;

ARTICLE; DIAGNOSTIC ACCURACY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEPATITIS A; HEPATITIS A VIRUS; IMMUNOADSORBENT; PRIORITY JOURNAL; SERODIAGNOSIS;

ACUTE DISEASE; ANTIGENS, VIRAL; CAPSID; CAPSID PROTEINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES, B-LYMPHOCYTE; HEPATITIS A; HEPATITIS A ANTIBODIES; HEPATITIS A ANTIGENS; HEPATITIS ANTIBODIES; HUMANS; IMMUNOLOGIC TESTS; PALMITIC ACID; PEPTIDE FRAGMENTS; PEPTIDES; REAGENT KITS, DIAGNOSTIC; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; VIRAL STRUCTURAL PROTEINS;

HEPATITIS A VIRUS; MIRIDAE;

EID: 0042297617     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-1759(99)00196-9     Document Type: Article

References (32)

1. Ahlborg N. Synthesis of a diepitope multiple antigen peptide containing sequences from two malaria antigens using Fmoc chemistry. J. Immunol. Methods. 179:1995;269.
2. Böcher M., Böldicke T., Kieb M., Bilitewski U. Synthesis of mono- and bifunctional peptide-dextran conjugates for the immobilization of peptide antigens on ELISA plates: properties and application. J. Immunol. Methods. 208:1997;191.
3. Bosch A., González-Dankaart J.F., Haro I., Gajardo R., Pérez J.A., Pintó R.M. A new continuous epitope of hepatitis A virus. J. Med. Virol. 54:1998;95.
4. Briand J.-P., Barin C., Van Regenmortel M.H.V., Muller S. Application and limitations of the multiple antigen peptide (MAP) system in the production and evaluation of anti-peptide and anti-protein antibodies. J. Immunol. Methods. 156:1992;255.
5. Favorov M.O., Khudyakov Y.E., Fieds H.A., Khudyakova N.S., Padhye N., Alter M.J., Mast E., Polish L., Yashina T.L., Yarasheva D.M., Onischenko G.G., Margolis H.S. Enzyme immunoassay for the detection of antibody to hepatitis E virus based on synthetic peptides. J. Virol. Methods. 46:1994;237.
6. Firsova, T., Pérez, J.A., Reig, I., Kruglov, I., Haro, I., 1998. Synthesis of a diepitope multiple antigen peptide containing sequences from VP1 and VP3 proteins of hepatitis A virus and its use in hepatitis A diagnosis. In: Ramage, R., Epton, R. (Eds.), Peptides 1996. Mayflower Scientific, UK, p. 383.
7. Francis M.J., Hastings G.Z., Brown F., McDermed J., Lu Y.A., Tam J.P. Immunological evaluation of the multiple antigen peptide (MAP) system using the major immunogenic site of foot- and-mouth disease virus. J. Immunol. 73:1991;249.
8. García M., Pujol M., Reig F., Alsina M.A., Haro I. Synthesis, lipophilic derivatization and interaction with liposomes of HAV-VP3(110-121) sequence by using spectroscopic techniques. Analyst. 121:1996;1583.
9. Gevorkian G., Soler C., Viveros M., Padilla A., Govezensky T., Larralde C. Serologic reactivity of a synthetic peptide from human immunodeficiency virus type 1 gp41 with sera from a Mexican population. Clin. Diagn. Lab. Immunol. 3(6):1996;651.
10. Gnann J.W., McCormick J.B., Mitchell S., Nelson J.A., Oldstone M.B.A. Synthetic peptide immunoassay distinguishes HIV type 1 and HIV type 2 infections. Science. 237:1987;1346.
11. Gómez C.E., López-Campistrous A.E., Duarte C.A. An immunoassay with bovine serum albumin coupled peptides for the improved detection of anti V3 antibodies in HIV-1 positive human sera. J. Virol. Methods. 71:1998;7.
12. González L., Boyle R.W., Zhang M., Castillo J., Whittier S., Della-Latta P., Clarke L.M., George J.R., Fang X., Wang J.G., Hosein B., Wang C.Y. Synthetic-peptide-based enzyme-linked immunosorbent assay for screening human serum or plasma for antibodies to human immunodeficiency virus type 1 and type 2 et al. Clin. Diagn. Lab. Immunol. 4(5):1997;598.
13. Haro, I., Culleré, A.M., Pérez, J.A., Pintó, R.M., Bosch, A., Reig, F., 1994. Solid phase synthesis and immunogenicity of an antigenic peptide from hepatitis A virus: comparison of different systems for enhancing antibodies production. In: Epton, R. (Ed.), Innovation and Perspectives in Solid Phase Synthesis and Complementary Technologies. Mayflower Worldwide, Birmingham, p. 527.
14. Haro I., Pintó R.M., González-Dankaart J.F., Pérez J.A., Reig F., Bosch A. Anti-hepatitis A virus antibody response in mice elicited by different forms of a synthetic VP1 peptide. Microbiol. Immunol. 39:1995;485.
15. Ibarra H., Riedemann S., Frösner G., Reinhardt G., Gomez J.C., Cornejo A. Historia natural de la hepatitis viral A en adultos en Chile: clinica y laboratorio. GEN. 47:1993;25.
16. Langedijk J.P.M., Brandenburg A.H., Middel W.G.J., Osterhaus A., Meloen R.H., Oirschot J.T. A subtype-specific peptide-based enzyme immunoassay for detection of antibodies to the G protein of human respiratory syncytial virus is more sensitive than routine serological tests. J. Clin. Microbiol. 35(7):1997;1656.
17. Le T.P., Church L.W.P., Corradin G., Hunter R.L., Charoenvit Y., Wang R., Vega P., Sacci J., Ballou W.R., Kolodny N., Kivot S., Glenn G.M., Richards R.L., Alving C.R., Hoffman S.L. Immunogenicity of Plasmodium falciparum circumsporozoite protein multiple antigen peptide vaccine formulated with different adjuvants. Vaccine. 16(2/3):1998;305.
18. Lemon, S.M., Ping, L.H., 1989. In: Semler, B.L., Ehrenfeld, E. (Eds.), Molecular Aspects of Picornavirus Infection and Detection, p. 193.
19. Marsden H.S., Owsianka A.M., Graham S., McLean G.W., Robertson C.A., Subak-Sharpe J.H. Advantages of branched peptides in serodiagnosis. Detection of HIV-specific antibodies and the use of glycine spacers to increase sensitivity. J. Immunol. Methods. 147:1992;65.
20. Martín I., Haro I., Reig F., Alsina M.A. Synthesis and physicochemical study of hepatitis A viral-VP1 protein peptides. Langmuir. 10(3):1994;784.
21. Mota F.M., Busquets M.A., Reig F., Alsina M.A., Haro I. Physicochemical study of several peptide constructs based on the sequence (96-107) of VP2-HAV protein. J. Colloid Interface Sci. 188:1997;81.
22. Nardin E.H., Oliveira G.A., Calvo-Calle J.M., Nussenzweig R.S. The use of multiple antigen peptides in the analysis and induction of protective immune responses against infectious diseases. Adv. Immunol. 60:1995;105.
23. Pérez J.A., González-Dankaart J.F., Reig F., Pintó R.M., Bosch A., Haro I. Solid phase synthesis and immunogenicity of a VP3 peptide from hepatitis A virus. Biomed. Pept., Proteins Nucleic Acids. 1(2):1995;93.
24. Pintó R.M., González-Dankaart J.F., Sánchez F., Guix S., Gómara M.J., García M., Haro I., Bosch A. Immunogenicity of a synthetic peptide bearing a new epitope of hepatitis A virus. FEBS Lett. 438:1998;106.
25. Qi Z., Cui D., Pan W., Yu C., Song Y., Cui H., Arima T. Synthesis and application of hepatitis E virus peptides to diagnosis. J. Virol. Methods. 55:1995;55.
26. Riedemann S., Reinhardt G., Frösner G., Ibarra H., Moraleda L., Hering V. Placebo-controlled efficacy study of hepatitis A vaccine in Valdivia, Chile. Vaccine. 10(11):1992;152.
27. Riedemann S., Ibarra H., Reinhardt G., Frösner G., Safary A. Prevalencia de anticuerpos anti-hepatitis A en la década actual. Rev. Med. Chile. 126:1998;1161.
28. Sabbatini A., Dolcher M.P., Marchini B., Bombardieri S., Migliorini P. Mapping of epitopes on the SmD molecule: the use of multiple antigen peptides to measure autoantibodies in systemic lupus erythematosus. J. Rheumatol. 20:1993;1679.
29. Shin S.Y., Lee M.K., Kim S.Y., Jang S.Y., Hahm K.-S. The use of multiple antigenic peptide (MAP) in the immunodiagnosis of human immunodeficiency virus infection. Biochem. Mol. Biol. Int. 43(4):1997;713.
30. Tam J.P. Recent advances in multiple antigen peptides. J. Immunol. Methods. 196:1996;17.
31. Tam J.P., Zavala F. Multiple antigen peptide. A novel approach to increase detection sensitivity of synthetic peptides in solid-phase immunoassays. J. Immunol. Methods. 124:1989;53.
32. Wu C.-L., Leu T.-S., Chang T.-T., Shiau A.-L. Hepatitis C virus protein fused to hepatitis B virus core antigen for serological diagnosis of both hepatitis C and hepatitis B infections by ELISA. J. Med. Virol. 57:1999;104.